Atomi Financial Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Atomi Financial Group's BIIB Position: Q2 2026 in Review
Atomi Financial Group increased its Biogen (BIIB) stake by 1.8% in Q2 2026, buying an estimated $9.56K and bringing the position to 2,792 shares worth $603K. The position accounts for 0.02% of the portfolio, ranked #684.
Atomi Financial Group first reported a position in BIIB in Q2 2025 and has held it in 4 quarters since. 1,045 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Atomi Financial Group held 2,792 shares of Biogen worth $603K as of Q2 2026.
- Atomi Financial Group bought 50 Biogen shares in Q2 2026, an estimated $9.56K.
- Biogen made up 0.02% of Atomi Financial Group's portfolio in Q2 2026, its #684 holding.
- Atomi Financial Group first reported a position in Biogen in Q2 2025 and has held it in 4 quarters since.
- 1,045 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.